Entries by Ayal Ronen

NINDS Presentation – New Programs to Support Therapy and Device Discovery and Development in Neurology

Presenter: Dr. Rajesh Ranganathan Director of the Office of Translational Research at NINDS The Office of Translational Research (OTR) at the National Institute of Neurological Disorders and Stroke at the National Institutes of Health, facilitates the preclinical discovery and development of new therapeutic interventions for neurological disorders. The OTR offers five programs that support the […]

/0 Comments/by

NIAID Presentation – Resources for the Microbiology and Infectious Diseases Research Community

Presenter: Dr Shy Shorer – Director, Office of Clinical Research Affairs (OCRA) – DMID, National Institute of Allergy and Infectious Diseases (NIAID) In his talk, Dr. Shy Shorer, the Director of the Office of Clinical Research Affairs (OCRA) in the Division of Microbiology and Infectious Diseases (DMID) of the National Institute of Allergy and Infectious […]

/0 Comments/by

Notes from the 10th Annual Non-Dilutive Funding Summit

The Non-Dilutive Funding Summit came together on January 14th, 2015 for the tenth consecutive year. The ~300 life science executives who attended the day long activities learned about Neuroscience Funding Opportunities related to the mission of the National Institute of Neurological Disorders and Stroke (NINDS) from Dr Rajesh Ranganathan, as well as a detailed description […]

/0 Comments/by

Ebola Non Dilutive Funding Opportunities

With the recent Ebola outbreak in Western Africa and subsequent extensive media coverage and public concern, Federal Agencies are teaming together to support novel research in the fight to eradicate this deadly disease. In this webinar FreeMind experts will share insight into the Ebola funding space as well as describe in detail current funding opportunities […]

/0 Comments/by

Non-Dilutive Funding Summit – January 14, 2015

[vc_row][vc_column width=”1/1″][pt_heading h=”H1″ heading=”Non-Dilutive Funding Summit” text_align=”align-left”][pt_marginblock measure=”px”]50[/pt_marginblock][pt_leadtext text_align=”align-left”] Join over 400 life science industry leaders in a full day of non-dilutive funding activities at the 10th Annual Non-dilutive Funding Summit, taking place on Wednesday January 14th, 2015 at the Nikko Hotel San Francisco. The summit is proud to host Dr. Rajesh Ranganathan, the Director […]

/0 Comments/by

Webinar: Step by Step Registration Guide

Registration is a multi-step process that can take 8 weeks or more and MUST be completed before the submission deadline. Organizations must be registered with the System for Award Management (SAM), Grants.gov and eRA Commons. The registration process is not sequential. As soon as an organization has obtained its DUNS number, it can begin registering […]

/0 Comments/by

Webinar: SBIR/STTR Funding; Driving Innovation Through Non-Dilutive Sources

SBIR/STTR awards account for over $780,000,000 awarded per year by NIH alone to industry. These are excellent sources of funding aimed at promoting R&D activities of small businesses as well as collaborations with Academics. SBIR/STTRs differ from traditional NIH mechanisms in that they are highly product driven and ultimately are seeking commercialization of novel therapies, […]

/0 Comments/by

Webinar: Medical Device Non Dilutive Funding Trends & Opportunities

In a world in which both medical diagnostics and therapies are shifting towards minimally invasive technologies, it is not surprising that steadily increasing non-dilutive funding is available for innovative medical device companies. The scope of funding support covers the entire R&D cycle, from early stage exploratory and discovery work all the way to late stage […]

/0 Comments/by

Webinar: Details of a Detailed Budget

Assembling a budget for your grant is typically the last item to be addressed. Reason being that the figures you are suggesting must reflect the work you are proposing to complete. That said, simply stating the cost per item is hardly enough, and a properly constructed justification is mandatory and weighs heavily on approval of […]

/0 Comments/by